Most Recent
A Victorian couple has launched a lawsuit against global giant Sony, alleging the company's TV had a safety defect that caused a house fire resulting in $1.6 million worth of damages and the loss of the family dogs.
Clyde & Co has brought on an insurance partner from Carter Newell, along with her team, marking the sixth partner the firm has added in the past year.
In a change of heart, a judge has appointed two barristers to act as contradictors in argument over the funder's proposed $244 million cut of a record $750 million settlement in two Toyota class actions.
Ford faces a product liability class action alleging the car giant sold vehicles with defective transmission that resulted in loss of power, shuddering gearboxes and grinding gear changes.
A new judge has joined the Victorian Supreme Court bench, after 28 years at the bar where he acted on product liability class actions, including a case against Monsanto over allegedly carcinogenic weed killer.
A class action against Allergan over recalled breast implants is trying again to strike out the US drug company’s defence that there was no known causal link between its implants and a type of cancer at the time of supply.
In ordering early registration for a class action against a Johnson & Johnson unit, which estimates its defence costs at over $22 million, a judge has said the "very expensive" process is appropriate.
Johnson & Johnson has agreed to pay $7.9 billion to resolve multi-district litigation in the US alleging its talcum powder caused cancer, a settlement Shine Lawyers said was a positive development as it readies for a first case management hearing in its class action.
Defence lawyers are bracing for a wave of class actions over companies’ use of generative artificial intelligence, with privacy, discrimination, consumer, product liability and shareholder claims expected.
US drug maker Pfizer has been hit with a class action alleging it knew or ought to have known about the increased risk that patients who used its injectable contraceptive Depo-Provera could develop brain tumors.